Cytosorbents (CTSO) Gross Margin (QoQ) (2012 - 2026)
Cytosorbents (CTSO) Gross Margin (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.38 Bn | 196.77 Bn | 7.27 Bn |
| 2 | Stryker | 126.28 Bn | 122.80 Bn | 4.50 Bn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.10 Bn | 73.56 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.67 Bn | 47.42 Bn | 1.35 Bn |
| 6 | Dexcom | 35.07 Bn | 33.12 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.20 Bn | 22.88 Bn | 4.55 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn |
| 10 | Cytosorbents | 23.55 Mn | 19.13 Mn | 7.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 402.00 |
| Mar 31, 2026 | -453.00 |
| Dec 31, 2025 | 340.00 |
| Sep 30, 2025 | -57.00 |
| Jun 30, 2025 | -27.00 |
| Mar 31, 2025 | 277.00 |
| Dec 31, 2024 | 733.00 |
| Sep 30, 2024 | -1,252.00 |
| Jun 30, 2024 | -292.00 |
| Mar 31, 2024 | 1,519.00 |
| Dec 31, 2023 | -236.00 |
| Sep 30, 2023 | -25.00 |
| Jun 30, 2023 | 615.00 |
| Mar 31, 2023 | -358.00 |
| Dec 31, 2022 | 1,671.00 |
| Sep 30, 2022 | -1,361.00 |
| Jun 30, 2022 | -1,559.00 |
| Mar 31, 2022 | 276.00 |
| Dec 31, 2021 | -373.00 |
| Sep 30, 2021 | -269.00 |